Inventor profile of:

Christopher W. Gregory

City:

Cary, North Carolina

Country:

United States

Published Applications:

10

Last publication date:

2011-11-24

Top Assignees for applications by Christopher W. Gregory

The entities that hold a legal rights for patent applications filed by inventor Gregory Christopher W.:

Recent patent applications by Gregory Christopher W.

Christopher W. Gregory from Cary, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2011-11-24
US20110286998A1
Human necessities

METHODS FOR TREATING AND PREVENTING CANCERS THAT EXPRESS THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS OF HORMONES AND RECEPTORS

#2 | 2011-08-11
US20110195898A1
Human necessities

TREATMENT OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT USING GNRH-I ANALOGS AND ONE OR MORE OF ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONISTS

#3 | 2009-08-06
US20090197796A1
Human necessities

Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors

#4 | 2008-09-04
US20080214639A1
Human necessities

Leuprolide acetate and acetylcholinesterase inhibitors/NMDA receptor antagonists for the treatment of alzheimer's disease

#5 | 2008-07-17
US20080171736A1
Human necessities

Treatment of Alzheimer's Disease and Mild Cognitive impairment using GnRH-I analogs and one or more of acetylcholinesterase inhibitors and NMDA receptor antagonists

#6 | 2007-10-11
US20070238647A1
Human necessities

Methods for treating prostate cancer

#7 | 2007-01-18
US20070015713A1
Human necessities

Methods for treating prostate cancer

#8 | 2006-10-19
US20060234918A1
Human necessities

Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors

#9 | 2006-07-06
US20060148697A1
Human necessities

Methods for treating and preventing brain cancers

#10 | 2006-06-29
US20060142186A1
Human necessities

Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer's disease

InventorID:

3481268 ⎘